The presence of atrial fibrillation carries a thromboembolic risk and the CHADS2 (clinical prediction rule for estimating the risk of stroke in non-rheumatic or non-valvular atrial fibrillation) scoring system can assist in determining the degree of risk as well as guide in the decision regarding the use of warfarin.28